Worth Venture Partners, LLC
- SEC CIK
- 0001696778
- Latest filing
- Aug 10, 2026
PCSA holding history
Processa Pharmaceuticals, Inc. in every 13F filed by Worth Venture Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PCSA overviewAll 13F holders of PCSAFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −70,954−100.0% | Sold out | Holders |
| Q4 2022 | 70,954 | $78.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 70,954 | $160.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 70,954 | $251.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2022 | 70,954 | $214.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 70,954 | $348.0K | 0.2% | −20,014−22.0% | Reduced | Holders |
| Q3 2021 | 90,968 | $780.0K | 0.4% | 00.0% | Unchanged | Holders |
| Q2 2021 | 90,968 | $745.0K | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2021 | 90,968 | $942.0K | 0.5% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.